Clinical Conversations in MS Care: Nursing Clinical Pearls for Building a Therapeutic Alliance

CME/CE Information
References

Activity Progress
Pre-Activity Survey
Page 1
Post-Activity Survey
CME Evaluation/Print Certificate

Problem: This activity is closed.

Clinical Conversations in MS Care: Nursing Clinical Pearls for Building a Therapeutic Alliance

Megan R. Weigel, DNP, ARNP-c, MSCN

Release Date: October 16, 2015

Expiration Date: October 15, 2016 (THIS ACTIVITY IS NO LONGER AVAILABLE FOR CREDIT)

Continue to Activity

ACTIVITY DESCRIPTION

This educational activity will provide nurses and nurse practitioners with the tools and skills to engage patients with MS in a therapeutic alliance, promoting collaborative decision-making in individualized care planning and restoring quality of life.

LEARNING OBJECTIVE

Upon completion of this educational activity, learners will be able to:

Implement strategies to educate and reinforce patient knowledge on treatment options for MS to facilitate health literacy and optimal clinical outcomes

FACULTY

Megan R. Weigel, DNP, ARNP-c, MSCN

Advanced Registered Nurse Practitioner

Baptist Neurology, PA

Jacksonville Beach, FL

FACULTY BIOGRAPHY

Megan R. Weigel, DNP, ARNP-c, MSCN, is an Advanced Registered Nurse Practitioner who has been practicing neurology for 13 years and has been an MS Certified Nurse for 9 of those years. She currently works at Baptist Neurology, Beaches Division in Jacksonville Beach, Florida, where she specializes in the care of MS patients. She received her Doctor of Nursing Practice degree from the University of Florida in 2009, with a research focus on preventive healthcare in MS patients. Dr Weigel was chosen as one of Jacksonville’s “40 Under 40” by the Jacksonville Business Journal in 2010, and received an Outstanding Young Alumnus award from the University of Florida in 2010. She was recently chosen to be President Elect for the International Organization of Multiple Sclerosis Nurses (IOMSN) and serves on the Editorial Board of the International Journal of MS Care. She is a member of the North Florida chapter of the National Multiple Sclerosis Society’s Clinical Advisory Committee and acts as their Research Advocate. Dr Weigel is an active speaker across the country, both to patients and healthcare providers on topics related to the care of people living with MS, and is the Co-Founder of oMS Yoga, a yoga program for people living with MS.

CONFLICTS OF INTEREST STATEMENT

According to the disclosure policies of NPA and the IOMSN, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence.

DISCLOSURE STATEMENTS

ACTIVITY FACULTY

Megan R. Weigel, DNP, ARNP-c, MSCN

Speakers Bureau: Acorda Therapeutics, Inc; Biogen Idec; EMD Serono, Inc; Genzyme Corporation; Mallinckrodt Pharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer Inc; Teva Pharmaceuticals

Consultant: Genzyme Corporation; Mallinckrodt Pharmaceuticals

NURSE PLANNER/REVIEWER

Nurse Practitioner Alternatives (NPA)

Laurie Scudder, DNP, NP, has served as nurse planner for this activity and has disclosed no relevant financial relationships.

EDUCATIONAL PLANNING COMMITTEE

International Organization of Multiple Sclerosis Nurses (IOMSN)

June Halper, MSN, APN-C, FAAN, MSCN

Consultant: Biogen Idec (non-CME research project)

Spire Learning

Christine Kocienda

Shareholder (spouse/partner): Johnson & Johnson; Procter & Gamble

Kashemi Rorie, PhD

Nothing to disclose with regard to commercial support

TARGET AUDIENCE

Nurses and nurse practitioners with an interest in the management of MS

ACCREDITATION

Nurses: This educational activity is co-provided by Nurse Practitioner Alternatives (NPA), the International Organization of Multiple Sclerosis Nurses (IOMSN), and Spire Learning.

NPA is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NPA designates this enduring activity for a maximum of 0.25 contact hours of continuing education for nurses and nurse practitioners.

METHOD OF PARTICIPATION

There is no fee for participating and receiving CE credit for this enduring activity, which should take approximately 15 minutes to complete. If you wish to receive full credit for participating in this activity, you must view the online activity and complete the online evaluation with a 70% passing score on the posttest. We cannot award credit unless all steps are completed.

This educational activity is co-provided by Nurse Practitioner Alternatives (NPA), the International Organization of Multiple Sclerosis Nurses (IOMSN), and Spire Learning.

This activity is supported by independent, unrestricted educational grants from Genzyme Corporation, Mallinckrodt Pharmaceuticals, and Teva Pharmaceuticals.

This activity was developed by the IOMSN as a resource for MS nurses. IOMSN has developed the content with consideration for validity, fair balance, and accuracy and is proud to endorse the activity with its logo.

OFF-LABEL STATEMENT

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this activity.

USE OF BRAND NAMES

This activity includes the use of brand names to minimize any confusion associated with similar agents with various formulations.

GENERAL DISCLOSURE AND COPYRIGHT STATEMENT

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the NPA, IOMSN, or Spire Learning. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should critically appraise the information presented, and draw conclusions only after careful consideration of all available scientific information.

Copyright 2015 Spire Learning. All rights reserved. No part of this activity may be reproduced or transmitted in any other form or by any means electronic or mechanical without first obtaining written permission from Spire Learning, IOMSN, or NPA.

Spire Learning, IOMSN, and NPA reserve the right to cancel or modify the activity content, faculty, and activities as necessary.

References for Clinical Conversations in MS Care: Nursing Clinical Pearls for Building a Therapeutic Alliance

Harris C, Halper J. Multiple Sclerosis: Best Practice in Nursing Care. Disease Management, Pharmacological Treatment, and Nursing Research. 4th ed. http://iomsn.org/images/pdf/BestPractices_4th.pdf. Accessed May 18, 2015.
Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35-44.
Remington G, Rodriguez Y, Logan D, et al. Facilitating medication adherence in patients with multiple sclerosis. Int J MS Care. 2013;15:36-45.
National Academy of Sciences. Health literacy: a prescription to end confusion. 2004. https://www.iom.edu/Reports/2004/Health-Literacy-A-Prescription-to-End-Confusion.aspx. Accessed May 18, 2015.
Wheeler KJ, Roberts ME, Neiheisel MB. Medication adherence part two: predictors of nonadherence and adherence. J Am Assoc Nurse Pract. 2014;26:225-232.
Caon C, Saunders C, Smrtka J, et al. Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data. J Neurosci Nurs. 2010;42(5 suppl):S5-S9.
Portaccio E, Zipoli V, Siracusa G, et al. Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis. Eur Neurol. 2008;59(3-4):131-135.
Turner AP, Kivlahan DR, Sloan AP, et al. Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model. Mult Scler. 2007;13:1146-1152.
Hancock LM, Bruce JM, Lynch SG. Exacerbation history is associated with medication and appointment adherence in MS. J Behav Med. 2011;34(5):330-338.
Neiheisel MB, Wheeler KJ, Roberts ME. Medication adherence part one: understanding and assessing the problem. J Am Assoc Nurse Pract. 2014;26:49-55.
Costello K, Halper J. Advanced Practice Nursing in Multiple Sclerosis: Advanced Skills, Advancing Responsibilities. 3rd ed. Expert Medical Education. 2010.
Smrtka J, et al. The Dynamic MS Nurse: Challenges, Expanding Role, and Future Directions. 2010. http://www.iomsn.org/images/pdf/Article_Advanced_NYCMSNurse.pdf. Accessed May 18, 2015.
Sutton JP, Schur C, Feldman J, et al. Comprehensive care centers and treatment of people with multiple sclerosis. Int J MS Care. 2007;9:104-110.